Company Filing History:
2 out of 50 
1 out of 11 Years Active: 2001-2007
Title: Christoph Kratky: Innovator in Hydroxynitrile Lyase Research
Introduction
Christoph Kratky, a notable inventor based in Graz, Austria, has made significant contributions to the field of biotechnology, particularly in the area of hydroxynitrile lyase activity. With a repertoire of three patents, his work holds promise for applications in various industrial processes.
Latest Patents
Kratky's latest patents revolve around isolated proteins and the genetic sequences that code for hydroxynitrile lyase. One of his key patents introduces new genes containing a DNA sequence coding for this enzyme, which can be engineered using specific primer combinations. The innovative techniques involve amplification using a DNA polymerase and cloning processes derived from organisms harboring these genes. His recombinant proteins can be expressed in suitable host cells, with further application in the production of (R)- or (S)-cyanohydrins, providing significant advancements in synthetic biology applications.
Another patent focuses on the genes coding for hydroxynitrile lyase and their recombinant proteins having specific enzymatic activities. This research underlines the potential uses of these proteins and fusion proteins in commercial settings, further extending Kratky's impact within the field.
Career Highlights
Christoph Kratky has held positions at reputable companies such as DSM Fine Chemicals Austria GmbH and DSM Fine Chemicals Austria Nfg GmbH & Co Kg. His roles in these organizations have positioned him at the forefront of chemical and biochemical innovations, significantly influencing product development through his technical expertise.
Collaborations
Throughout his career, Kratky has collaborated with notable peers including Helmut Schwab and Anton Glieder. These professional relationships have facilitated knowledge exchange and enhanced the innovative capacity of his research, fostering growth in hydroxynitrile lyase studies.
Conclusion
With a strong foundation in biotechnology and a robust portfolio of patents, Christoph Kratky continues to be an influential figure in the development of hydroxynitrile lyase technologies. His innovative spirit and collaborative efforts signify a promising future in the applications of his research, contributing substantially to advancements in the field.